In fact, the FDA designated BPC-157 as a Category 2 bulk drug substance, meaning it cannot be compounded by commercial pharmaceutical companies due to insufficient safety evidence in humans
Product Format & Classification This compound is offered in a research format intended for educational and laboratory contexts
We manufacture both RJT (Ring Joint Type) and IDF seals in a range of standard and non-standard polymers, tailored to suit different temperatures, cleaning processes and application needs
Reported Adverse Effects Reported adverse effects from online forums cited in a 2025 systematic review (PMC12313605) included: Anxiety and panic attacks Depression and anhedonia Insomnia Heart palpitations Fatigue and weakness Loss of appetite These anecdotal reports cannot be verified as directly caused by BPC-157 versus contamination, incorrect dosing, or concurrent conditions, but they raise concerns that the peptide might paradoxically worsen mental health in some individuals
Frequently Asked Questions Q: How soon will I feel a difference
Hu D, Zhang X, Gong S, Ma W, Cheng B, Yang J, Yan L, Li B, Qiu T, Wang X (2025) An injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-inflammatory and antioxidant